These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 1395189)
21. Torsade de pointes: the clinical considerations. Gowda RM; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ Int J Cardiol; 2004 Jul; 96(1):1-6. PubMed ID: 15203254 [TBL] [Abstract][Full Text] [Related]
22. Assessment of Safety Margin of an Antipsychotic Drug Haloperidol for Torsade de Pointes Using the Chronic Atrioventricular Block Dogs. Izumi-Nakaseko H; Nakamura Y; Cao X; Wada T; Ando K; Sugiyama A Cardiovasc Toxicol; 2017 Jul; 17(3):319-325. PubMed ID: 27738880 [TBL] [Abstract][Full Text] [Related]
23. Ciprofloxacin-induced torsade de pointes. Flanagan MC; Mitchell ES; Haigney MC Int J Cardiol; 2006 Nov; 113(2):239-41. PubMed ID: 16386810 [TBL] [Abstract][Full Text] [Related]
24. Changes in frequency domain measures of heart rate variability in relation to the onset of ventricular tachycardia in acute myocardial infarction. Valkama JO; Huikuri HV; Airaksinen KE; Linnaluoto MK; Takkunen JT Int J Cardiol; 1993 Feb; 38(2):177-82. PubMed ID: 8454380 [TBL] [Abstract][Full Text] [Related]
25. Development of torsade de pointes caused by exacerbation of QT prolongation during clipping of cerebral artery aneurysm in a patient with subarachnoid haemorrhage. Takenaka I; Aoyama K; Iwagaki T; Ishimura H; Kadoya T Br J Anaesth; 2006 Oct; 97(4):533-5. PubMed ID: 16849385 [TBL] [Abstract][Full Text] [Related]
26. ['Cardiac ballet' with and without amiodarone]. Balestra B; Hess T Schweiz Med Wochenschr; 1993 Jan; 123(1-2):20-5. PubMed ID: 8421775 [TBL] [Abstract][Full Text] [Related]
27. Torsades de pointes associated with acquired long QT syndrome: observation of 7 cases. Takahashi N; Ito M; Inoue T; Koumatsu K; Takeshita Y; Tsumabuki S; Tamura M; Inoue K; Maeda T; Saikawa T J Cardiol; 1993; 23(1):99-106. PubMed ID: 8164140 [TBL] [Abstract][Full Text] [Related]
28. Are serial Holter QT, late potential, and wavelet measurement clinically useful? Rubel P; Hamidi S; Behlouli H; Couderc JP; Fayn J; Forlini MC; Maison-Blanche P; Miquel M; Coumel P; Touboul P J Electrocardiol; 1996; 29 Suppl():52-61. PubMed ID: 9238378 [TBL] [Abstract][Full Text] [Related]
29. Risk factors and predictors of Torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving Dofetilide. Pedersen HS; Elming H; Seibaek M; Burchardt H; Brendorp B; Torp-Pedersen C; Køber L; Am J Cardiol; 2007 Sep; 100(5):876-80. PubMed ID: 17719337 [TBL] [Abstract][Full Text] [Related]
30. Takotsubo cardiomyopathy as a potential cause of long QT syndrome and torsades de pointes. Ghosh S; Apte P; Maroz N; Broor A; Zeineh N; Khan IA Int J Cardiol; 2009 Aug; 136(2):225-7. PubMed ID: 18617280 [TBL] [Abstract][Full Text] [Related]
32. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade. Skanes AC; Morton BC; Green MS; Tang AS Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970 [TBL] [Abstract][Full Text] [Related]
33. [T-wave alternans and Torsade de Pointes ventricular tachycardia in a patient with intracerebral hemorrhage]. Tomcsányi J; Somlói M; Frész T; Beck K Orv Hetil; 2003 Oct; 144(42):2077-9. PubMed ID: 14658420 [TBL] [Abstract][Full Text] [Related]
34. Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes. Lazzerini PE; Laghi-Pasini F; Bertolozzi I; Morozzi G; Lorenzini S; Simpatico A; Selvi E; Bacarelli MR; Finizola F; Vanni F; Lazaro D; Aromolaran A; El Sherif N; Boutjdir M; Capecchi PL Heart; 2017 Nov; 103(22):1821-1829. PubMed ID: 28490617 [TBL] [Abstract][Full Text] [Related]
35. The Clue Is in the U Wave: Torsades de Pointes Ventricular Tachycardia in a Hypokalemic Woman on Methadone. Fitzpatrick JK; Goldschlager N Ann Emerg Med; 2018 Apr; 71(4):473-476. PubMed ID: 29566890 [No Abstract] [Full Text] [Related]
36. Torsade de pointes associated with encephalitis. Alehan D; Ceviz N; Celiker A Turk J Pediatr; 1999; 41(3):395-8. PubMed ID: 10770105 [TBL] [Abstract][Full Text] [Related]
38. Drug-induced torsade de pointes. Incidence, management and prevention. Faber TS; Zehender M; Just H Drug Saf; 1994 Dec; 11(6):463-76. PubMed ID: 7727055 [TBL] [Abstract][Full Text] [Related]
39. [Clinical observation on pause-dependent long QT syndrome and torsade de pointes ventricular tachycardia]. Song YC Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Dec; 20(6):349-51, 389. PubMed ID: 1307971 [TBL] [Abstract][Full Text] [Related]
40. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit. Jacobson I; Carlsson L; Duker G J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]